Clin2
NCT07768111Likely a fitNot yet recruiting

Drug interaction study for healthy volunteers

Drug Interaction Research

This study looks at how a new medicine (Flonoltinib Maleate) interacts with other drugs in healthy adults. It helps doctors understand safe dosing and potential effects before the medicine is tested in patients.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
40 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are a healthy adult aged 18 to 45.
  • Your weight is at least 50 kg (men) or 45 kg (women), and your body mass index (BMI) is between 19 and 26.
  • You can attend all study visits and follow the study rules.
  • You are willing to avoid alcohol, grapefruit, coffee, tea, and other caffeinated drinks for 48 hours before the study starts.
  • You do not have a history of drug abuse or a positive drug test.
  • You are comfortable with blood draws and do not have a fear of needles or blood.
  • You do not have certain infections (like hepatitis B, hepatitis C, syphilis, or HIV).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07809815Recruiting· Phase 1
Drug interaction study of befotertinib in healthy volunteers

This study checks how befotertinib, an experimental cancer drug, interacts with other drugs in healthy people. It helps make sure the drug is safe and works well when taken with other medicines.

Hangzhou, Zhejiang
NCT07341672Not yet recruiting· Phase 1
How other medicines affect a new drug in healthy people

This study tests a new drug (clifutinib) in healthy volunteers to see how other common medicines (itraconazole, fluconazole, and efavirenz) affect its levels in the body. The results will help doctors understand how to dose clifutinib in future patients.

Jinan, Shandong
NCT07438886Not yet recruiting· Phase 1
Drug interaction study with catequentinib in healthy adults

This study checks how a new investigational drug (catequentinib) interacts with two other common medications in healthy volunteers. Participation helps understand safe dosing and potential side effects before larger studies.

Beijing, Beijing Municipality
NCT07766369Recruiting· Phase 1
Drug interaction study for healthy adults

This trial tests how a new drug, E2086, interacts with other medicines in healthy volunteers. It helps make sure the drug is safe and works properly when combined with common medications.

Austin, Texas
NCT07744802Recruiting· Phase 1
Drug interaction study of vimseltinib in healthy men

This study is for healthy men to see how a new drug called vimseltinib affects a protein in your body that helps remove other drugs. Participation will help your doctors understand how to use this drug safely in the future.

Overland Park, Kansas
NCT07162441Recruiting· Phase 1
Drug interaction study in healthy volunteers

This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.

Seoul, Gwanak-gu

Hear when a new Drug Interaction Research trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.